Related Experiment Video
Updated: Aug 8, 2026

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
The actin-ADP-ribosylating Clostridium botulinum C2 toxin
1Institut für Experimentelle und Klinische, Pharmakologie und Toxikologie, Albert-Ludwigs, Universität Freiburg, Albertstrasse 25, D-79104 Freiburg, Germany. klaus.aktories@pharmakol.uni-freiburg.de
Abstract:
Clostridium botulinum C2 toxin is the prototype of actin-ADP-ribosylating toxins. The toxin consists of the enzyme component C2I and the separated binding/translocation component C2II. C2II is proteolytically activated to form heptamers, which bind the enzyme component. After endocytosis of the receptor-toxin complex, the enzyme component enters the cytosol from an acidic endosomal compartment to modify G-actin at arginine177. Recent data indicate that chaperons are involved in the translocation process of the toxin.
Related Concept Videos
Botulism
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Tetanus
Bacterial Toxins
Bacterial Phylum Actinobacteria
Diphtheria

